Monday, September 7

Recent developments in digital health and life sciences highlight significant funding and innovations aimed at enhancing patient care and treatment options.

  1. Kāhu SiliconBio has secured £1.2 million in funding to further develop its bioelectronic sensing platform for real-time hormone monitoring, aiming to improve diagnosis and management of hormone-related conditions through continuous data tracking.

  2. Mirae, an AI-driven platform focusing on inflammatory bowel disease (IBD), raised $5.4 million in seed funding to help capture and analyze patient health data, facilitating more effective specialty care and precision medicine.

  3. DITTO, a menstrual health startup, raised $6 million for expanding its clinical-grade supplement offerings, particularly targeting symptoms of PMS and PMDD with a novel delivery technology that shows promising clinical results.

  4. Qureight closed a $20 million Series B funding round to enhance its imaging Contract Research Organization (CRO) services for complex cardiothoracic conditions, leveraging AI for more efficient clinical trials.

  5. Mironid secured $46 million in Series B funding to advance its therapies for autosomal dominant polycystic kidney disease (ADPKD), focusing on innovative small molecule treatments that target cyst growth mechanisms.

  6. Psyomics received an Innovate UK loan to evolve its digital mental health technology into a regulated medical device, aiming to streamline mental health service delivery within the NHS.

  7. Silence Therapeutics announced a $175 million public offering to support its mRNAi GOLD platform, which develops siRNA therapeutics targeting genetic diseases, further advancing its clinical pipeline.

These developments reflect a growing trend towards leveraging technology and innovation to address complex health issues and improve patient outcomes.

Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.

Link to original article source: https://healthcaretoday.com/article/capital-raising-in-healthtech-kahu-siliconbio-mirae-ditto

Leave A Reply